fosquidone has been researched along with Cancer of Ovary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cavalli, F; Clavel, M; Judson, IR; Kaye, SB; Piccart, MJ; Smyth, JF; Ten Bokkel Huinink, WW; Verweij, J; Wagener, DJ; Wanders, J | 1 |
Boven, E; Erkelens, CA; Luning, M; Pinedo, HM | 1 |
1 trial(s) available for fosquidone and Cancer of Ovary
Article | Year |
---|---|
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Isoquinolines; Male; Melanoma; Middle Aged; Organophosphorus Compounds; Ovarian Neoplasms | 1992 |
1 other study(ies) available for fosquidone and Cancer of Ovary
Article | Year |
---|---|
Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
Topics: Animals; Antineoplastic Agents; Cell Line; Female; Humans; Isoindoles; Isoquinolines; Mice; Mice, Nude; Neoplasm Transplantation; Organophosphorus Compounds; Ovarian Neoplasms; Quinones | 1990 |